Table 1.

Baseline characteristics

Characteristics at enrollment	N = 22
Age (years)	45.7 (20–73) ± 16.2
Males/females	13/9 (59.1/40.9)
Disease duration (years)	7.2 (0.8–28) ± 7.2
Disease extent
Extensive colitis	14 (63.6)
Left-sided colitis	7 (31.8)
Proctitis	1 (4.5)
CAI (Rachmilewitz index)	4.8 (1–9) ± 1.8
CRP (mg/dL)	0.47 (0.01–6.59) ± 1.10
Alb (g/dL)	4.03 (2.9–4.8) ± 0.49
Hb (g/dL)	12.87 (8.9–15.5) ± 1.97
MES
MES 0	1 (4.5)
MES 1	6 (27.3)
MES 2	12 (54.5)
MES 3	3 (13.6)
UCEIS	4.09 (2–7) ± 1.38
Other medication at start
Oral 5-ASA	13 (59.1)
Suppository steroids	3 (13.6)
Systemic steroids	3 (13.6)
History of biologics use	10 (45.5)

Data are presented as mean (range) ± standard deviation or n (%)

CAI clinical activity index, CRP C-reactive protein, Alb albumin, Hb hemoglobin, MES Mayo endoscopic subscore, UCEIS ulcerative colitis endoscopic index of severity, 5-ASA 5-aminosalicylic acid